MAVS and cardiac hypertrophy: Recently, it was reported that MAVS acted as downstream of nucleotide-binding oligomerization domain-containing protein 1/receptor-interacting protein 2 (NOD1/RIP2) to promote cardiac hypertrophy following pressure overload induced by transverse aortic constriction (TAC) (13).